SCHEMBL13403305

SCHEMBL13403305

COCCNC(=O)c1cccc(/C=C/C(=O)c2c(O)c3ccccc3oc2=O)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
MAPT P10636 4/20 0.50
KMT2A Q03164 3/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
NQO1 P15559 6/20 0.49
RAB9A P51151 2/20 0.48
MEN1 O00255 1/20 0.48
RECQL P46063 1/20 0.48
GPR55 Q9Y2T6 1/20 0.48
ALDH1A1 P00352 5/20 0.42
CA12 O43570 1/20 0.42
CA9 Q16790 1/20 0.42
HPGD P15428 4/20 0.41
GAA P10253 2/20 0.41
ALOX15 P16050 2/20 0.41
POLB P06746 1/20 0.41
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12374855 0.82 MEN1 (0.48) KDM4EMAPTKMT2ARAB9AMEN1
SCHEMBL13403294 0.82 MEN1 (0.51) KDM4EMAPTKMT2ACYP1A2CYP2C19
SCHEMBL13818097 0.79 PADI4 (0.40) KDM4EMAPTKMT2ACYP1A2CYP2C9
SCHEMBL4520097 0.78 PADI4 (0.40) KDM4EMAPTRAB9AALDH1A1HPGD
SCHEMBL4520101 0.78 PADI4 (0.40) KDM4EMAPTRAB9AALDH1A1HPGD
SCHEMBL2277602 0.75 LMNA (0.40) KDM4EMAPTKMT2ACYP1A2CYP2C9
SCHEMBL2277607 0.75 LMNA (0.40) KDM4EMAPTKMT2ACYP1A2CYP2C9
SCHEMBL12374701 0.73 ALDH1A1 (0.40) KDM4EMAPTKMT2ACYP1A2CYP2C9
SCHEMBL13818117 0.72 NQO1 (0.51) KDM4EMAPTKMT2ACYP1A2CYP2C9
SCHEMBL2281362 0.72 HPGD (0.57) KDM4EMAPTCYP1A2CYP2C19RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691883-B2 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-06 US disclosed
US-7691883-B2 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-06 US disclosed
US-20070265228-A1 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-11-15 US disclosed
US-20070265228-A1 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265228-A1 Cinnamoyl compound and use of the same NPC1, CES2, CYP51A1 KDM4E 2988/4885MAPT 2195/4885KMT2A 3443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.